Variables associated with human papillomavirus (HPV) vaccine acceptance by men

To determine correlates of human papillomavirus (HPV) vaccine acceptance for men. A convenience sample of men aged 18 to 45 years read a one-page information sheet about HPV and the HPV vaccine, then completed a 29-item questionnaire. chi(2) tests were used to determine whether differences in demogr...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Board of Family Medicine Vol. 22; no. 1; pp. 34 - 42
Main Authors Ferris, Daron G, Waller, Jennifer L, Miller, Jeremiah, Patel, Pratik, Price, George A, Jackson, Lanier, Wilson, Courtesia
Format Journal Article
LanguageEnglish
Published United States 01.01.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To determine correlates of human papillomavirus (HPV) vaccine acceptance for men. A convenience sample of men aged 18 to 45 years read a one-page information sheet about HPV and the HPV vaccine, then completed a 29-item questionnaire. chi(2) tests were used to determine whether differences in demographic, sexual, and vaccine-related variables existed between levels of wanting the HPV vaccine. Positive correlates of HPV vaccine acceptance included higher education (P < .0001); hispanic ethnicity (P = .0003); wearing a seat belt most of the time (P = .02); regular tobacco use (P = <.001); not being sexually active (P = .0008); history of more than 10 female sexual partners (P = .0004); not having oral sex (P = .045); extreme worry about vaccine side effects (P < .0001); extreme concern about vaccine safety (P < .0001); the importance of getting vaccines (P < .0001); familiarity with HPV (P < .0001); and extreme importance of receiving the HPV vaccine (P < .0001). Men with greater general education, high-risk behaviors, and knowledge about HPV are more likely to want the HPV vaccine. Focused educational efforts should facilitate even wider acceptance of the HPV vaccine by men.
AbstractList To determine correlates of human papillomavirus (HPV) vaccine acceptance for men. A convenience sample of men aged 18 to 45 years read a one-page information sheet about HPV and the HPV vaccine, then completed a 29-item questionnaire. chi(2) tests were used to determine whether differences in demographic, sexual, and vaccine-related variables existed between levels of wanting the HPV vaccine. Positive correlates of HPV vaccine acceptance included higher education (P < .0001); hispanic ethnicity (P = .0003); wearing a seat belt most of the time (P = .02); regular tobacco use (P = <.001); not being sexually active (P = .0008); history of more than 10 female sexual partners (P = .0004); not having oral sex (P = .045); extreme worry about vaccine side effects (P < .0001); extreme concern about vaccine safety (P < .0001); the importance of getting vaccines (P < .0001); familiarity with HPV (P < .0001); and extreme importance of receiving the HPV vaccine (P < .0001). Men with greater general education, high-risk behaviors, and knowledge about HPV are more likely to want the HPV vaccine. Focused educational efforts should facilitate even wider acceptance of the HPV vaccine by men.
OBJECTIVETo determine correlates of human papillomavirus (HPV) vaccine acceptance for men.METHODSA convenience sample of men aged 18 to 45 years read a one-page information sheet about HPV and the HPV vaccine, then completed a 29-item questionnaire. chi(2) tests were used to determine whether differences in demographic, sexual, and vaccine-related variables existed between levels of wanting the HPV vaccine.RESULTSPositive correlates of HPV vaccine acceptance included higher education (P < .0001); hispanic ethnicity (P = .0003); wearing a seat belt most of the time (P = .02); regular tobacco use (P = <.001); not being sexually active (P = .0008); history of more than 10 female sexual partners (P = .0004); not having oral sex (P = .045); extreme worry about vaccine side effects (P < .0001); extreme concern about vaccine safety (P < .0001); the importance of getting vaccines (P < .0001); familiarity with HPV (P < .0001); and extreme importance of receiving the HPV vaccine (P < .0001).CONCLUSIONSMen with greater general education, high-risk behaviors, and knowledge about HPV are more likely to want the HPV vaccine. Focused educational efforts should facilitate even wider acceptance of the HPV vaccine by men.
Author Wilson, Courtesia
Miller, Jeremiah
Jackson, Lanier
Waller, Jennifer L
Patel, Pratik
Price, George A
Ferris, Daron G
Author_xml – sequence: 1
  givenname: Daron G
  surname: Ferris
  fullname: Ferris, Daron G
  email: dferris@mcg.edu
  organization: Department of Family Medicine and Obstetrics, Medical College of Georgia, Augusta, GA 30912-3500, USA. dferris@mcg.edu
– sequence: 2
  givenname: Jennifer L
  surname: Waller
  fullname: Waller, Jennifer L
– sequence: 3
  givenname: Jeremiah
  surname: Miller
  fullname: Miller, Jeremiah
– sequence: 4
  givenname: Pratik
  surname: Patel
  fullname: Patel, Pratik
– sequence: 5
  givenname: George A
  surname: Price
  fullname: Price, George A
– sequence: 6
  givenname: Lanier
  surname: Jackson
  fullname: Jackson, Lanier
– sequence: 7
  givenname: Courtesia
  surname: Wilson
  fullname: Wilson, Courtesia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19124631$$D View this record in MEDLINE/PubMed
BookMark eNpFkD1PwzAYhC1URGnhHyDkCcHQ4NeOHWdEFVCkChigq-U4b9RU-SJOivrvST8klrsb7m54JmRU1RUScgMsEMD548YmWRlwxuKAQcA0Y0yfkUuQUs8iAD065GjGFZdjMvF-w1gYCq4uyBhi4KEScEneV7bNbVKgp9b72uW2w5T-5t2arvvSVrSxTV4UdWm3edt7er_4XD3QrXUur5AOhk1nK4c02dESqytyntnC4_XJp-T75flrvpgtP17f5k_LmRMSukG1BK6ySFjOBAcZRbGSDrNUp1ZFWgqpRKIFZJnUoJVSHNNYszBxkicYiym5O_42bf3To-9MmXuHRWErrHtvlIpiqUIxFMNj0bW19y1mpmnz0rY7A8zsOZoDR7PnaBiYI8dhdnv675MS0__RCZz4A3l0cA0
CitedBy_id crossref_primary_10_1177_0739986320956913
crossref_primary_10_1111_j_1751_486X_2012_01701_x
crossref_primary_10_1097_OLQ_0b013e3181bf542c
crossref_primary_10_1371_journal_pone_0106686
crossref_primary_10_1007_s10935_013_0297_0
crossref_primary_10_1080_00325481_2022_2124791
crossref_primary_10_4018_JGIM_333611
crossref_primary_10_1158_1055_9965_EPI_09_1287
crossref_primary_10_1371_journal_pone_0198615
crossref_primary_10_1177_0033354917742117
crossref_primary_10_1089_jomh_2014_0022
crossref_primary_10_5388_aon_2014_14_3_173
crossref_primary_10_2190_IQ_34_1_h
crossref_primary_10_1016_j_vaccine_2012_04_066
crossref_primary_10_1080_01443615_2017_1317239
crossref_primary_10_1080_15546128_2013_860352
crossref_primary_10_1586_eog_10_42
crossref_primary_10_1016_j_vaccine_2012_07_001
crossref_primary_10_1016_j_vaccine_2012_07_045
crossref_primary_10_1016_j_jadohealth_2009_11_199
crossref_primary_10_1016_j_vaccine_2023_02_022
crossref_primary_10_1111_j_1466_7657_2012_00991_x
crossref_primary_10_4069_kjwhn_2011_17_4_415
crossref_primary_10_1097_CAD_0b013e328340fd18
crossref_primary_10_1007_s10900_013_9773_y
crossref_primary_10_1080_15546128_2016_1198733
crossref_primary_10_1136_sextrans_2013_051357
crossref_primary_10_1177_1557988319883776
crossref_primary_10_1177_1557988312456697
crossref_primary_10_12799_jkachn_2016_27_2_144
crossref_primary_10_1016_j_ypmed_2016_10_007
crossref_primary_10_5981_jjhnc_36_456
crossref_primary_10_1097_OLQ_0000000000000521
crossref_primary_10_1016_j_vaccine_2020_07_076
crossref_primary_10_1080_07448481_2013_872649
crossref_primary_10_1177_1557988310372802
crossref_primary_10_7739_jkafn_2012_19_2_201
crossref_primary_10_1080_19325037_2017_1343159
crossref_primary_10_1080_21645515_2016_1156271
crossref_primary_10_1177_0017896915572705
crossref_primary_10_3390_vaccines12010016
crossref_primary_10_1016_j_jomh_2011_04_002
crossref_primary_10_4161_hv_7_12_17980
crossref_primary_10_1108_HE_04_2015_0014
crossref_primary_10_1080_07448481_2011_552538
crossref_primary_10_1016_j_vaccine_2015_01_038
crossref_primary_10_1016_j_jadohealth_2010_03_003
crossref_primary_10_1016_j_nurpra_2010_10_002
crossref_primary_10_4161_hv_6_9_12730
crossref_primary_10_1016_j_jomh_2011_03_001
crossref_primary_10_1097_OLQ_0b013e3181e1a14c
crossref_primary_10_1089_heq_2021_0177
crossref_primary_10_1007_s10903_014_0067_y
crossref_primary_10_1080_00224499_2011_642904
crossref_primary_10_1016_S1473_3099_12_70031_2
crossref_primary_10_1097_01_NPR_0000388900_49604_e1
crossref_primary_10_1136_sextrans_2012_050980
crossref_primary_10_1016_j_vaccine_2011_03_060
crossref_primary_10_1097_OLQ_0000000000000226
crossref_primary_10_1080_01463373_2017_1356338
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.3122/jabfm.2009.01.080008
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-7118
EndPage 42
ExternalDocumentID 10_3122_jabfm_2009_01_080008
19124631
Genre Journal Article
Comparative Study
GroupedDBID ---
.GJ
18M
29L
2WC
5GY
5RS
5VS
6PF
AAWTL
ACGFO
ADBBV
ADPDF
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CGR
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
GX1
H13
M5~
M~E
NPM
OB4
OFXIZ
OHT
OVD
OVEED
PONUX
RHF
RHI
RNS
TEORI
TME
TR2
W8F
WOQ
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c351t-c385126f73a20321577965cefd8da67853563b831ff58186662ed9804bc52be93
ISSN 1557-2625
IngestDate Fri Aug 16 23:24:11 EDT 2024
Fri Aug 23 03:38:57 EDT 2024
Sat Sep 28 07:56:13 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c351t-c385126f73a20321577965cefd8da67853563b831ff58186662ed9804bc52be93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jabfm.org/content/jabfp/22/1/34.full.pdf
PMID 19124631
PQID 66795643
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_66795643
crossref_primary_10_3122_jabfm_2009_01_080008
pubmed_primary_19124631
PublicationCentury 2000
PublicationDate 2009 Jan-Feb
2009-01-01
20090101
PublicationDateYYYYMMDD 2009-01-01
PublicationDate_xml – month: 01
  year: 2009
  text: 2009 Jan-Feb
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of the American Board of Family Medicine
PublicationTitleAlternate J Am Board Fam Med
PublicationYear 2009
SSID ssj0044326
Score 2.1712284
Snippet To determine correlates of human papillomavirus (HPV) vaccine acceptance for men. A convenience sample of men aged 18 to 45 years read a one-page information...
OBJECTIVETo determine correlates of human papillomavirus (HPV) vaccine acceptance for men.METHODSA convenience sample of men aged 18 to 45 years read a...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 34
SubjectTerms Adolescent
Adult
Health Behavior
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines
Patient Acceptance of Health Care - statistics & numerical data
Risk Factors
Sex Factors
Statistics as Topic
Vaccination - statistics & numerical data
Young Adult
Title Variables associated with human papillomavirus (HPV) vaccine acceptance by men
URI https://www.ncbi.nlm.nih.gov/pubmed/19124631
https://search.proquest.com/docview/66795643
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF7cFEovpe-66WMPPbQYtdK-JB3b0tQEEnJIgm9iV1qBSSQLRw6kvz6zDz2cB7S9rM3KrOSZj9E3szszCH2SoigSnrOAFywMwOCxICUqCWIVwfutDEthc2EODsX8hO0v-GIyuRqdWtq06mv-5868kv_RKsyBXk2W7D9otl8UJuA76BdG0DCMf6XjU3B0TerTxUx6KXeHyV3rvUY2y_PzVSUvl-uNDa_Oj05NHOBS5mZDfQYfumlt1gDQ0Mqnhd3mqqP8k3r2Y2VCDzDrm2Yc3Nie3zPFHh07l2tTtGMctHcI6c7UzPrQ85CTuK_XuloOYeoj-Feuz7IB69lWmCIdhSm8ZeVxQITLcu5MLyG3IObsqAtw3jTvNCLEthVQZeVLjZoCrIbHjH8OSmoqq3JwRgkT_jWzXVa7u_QAPSRgo4xx_L3oTwcxRm2nvv6pXdaleYBvd93e1p51C24TnHu8Fstejp-iJ16V-LvD0DM00fVz9KjT3At02EMJD1DCBkrYQglvQwl_BiB9wR5GeIARVlcYYPQSnez9Ov45D3yrjSCnPGphBOZNRBlTSUIKNDCOU8FzXRZJIYHPcMoFVQmNypLbGomC6CJNQqZyTpRO6Su0U69q_QZhVoR5kqdCM2CqUUEkpXkstVC0VBrIzxQFnXyyxlVUycATNaLNrGhNZ9Q0C6PMiXaKPnZCzMD0mf0sWevV5iITIgbvntEpeu1kO6zndfH23iu76PGA0ndop11v9Hugl636YIFwDZyCdRQ
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Variables+associated+with+human+papillomavirus+%28HPV%29+vaccine+acceptance+by+men&rft.jtitle=Journal+of+the+American+Board+of+Family+Medicine&rft.au=Ferris%2C+Daron+G&rft.au=Waller%2C+Jennifer+L&rft.au=Miller%2C+Jeremiah&rft.au=Patel%2C+Pratik&rft.date=2009-01-01&rft.issn=1557-2625&rft.volume=22&rft.issue=1&rft.spage=34&rft_id=info:doi/10.3122%2Fjabfm.2009.01.080008&rft_id=info%3Apmid%2F19124631&rft.externalDocID=19124631
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1557-2625&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1557-2625&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1557-2625&client=summon